Prediabetes, dyslipidemia, arterial hypertension, metabolic liver diseases: at Valbiotis, our research targets the main metabolic and cardiovascular risk factors.
Prediabetes, dyslipidemia, arterial hypertension, metabolic liver diseases: at Valbiotis, our research targets the main metabolic and cardiovascular risk factors.
Four plant-based active substances in clinical development to reduce the risk of metabolic and cardiovascular diseases.
Nos gammes de compléments alimentaires Valbiotis®PRO et Valbiotis®PLUS disponibles sur notre site e-commerce Valbiotis® Healthcare
Découvrez nos solutions